Any current/future new fundraising through debt or equity?

There is no explicit mention of any current or future fundraising through debt or equity in the provided transcript. However, it is noted that the recently acquired NACL followed a rights issue of INR 250 crores to reduce high-cost debt. Coromandel International has made significant investments of over INR 3,000 crores in the last two years across business segments, indicating use of internal resources or financing, but no specific new fundraising is mentioned. The company is focusing on realizing value from current investments before making large new investments, particularly in the CDMO spac

Any current/future capex/capital investment/strategic investment?

Dhaksha facility expansion: Moving to a larger facility expected to be ready by May 2026, aiming to enhance drone production and execution of defense orders. Strengthening R&D: Plan to introduce new products in the next 6-9 months to capitalize on prior investments. Dahej plant: Expanded capacity by 10,000 tons of Mancozeb with payback less than one year; an additional 20,000-ton expansion underway at Sarigam expected by mid-2026. Technical MAP and seaweed granulation capacities are being set up in the specialty nutrient business to generate revenue in coming years. Fluorination chemis

Future growth expectations in sales/revenue/volumes?

Crop Protection business expects 20%-25% revenue growth driven by new registrations, product launches (six new products), and increased active ingredient volumes, especially Mancozeb with new capacities at Dahej and Sarigam. Formulation business growth projected at 14%-20%, with niche and bio pesticide products gaining traction. Nano DAP segment shows strong growth, with 60% volume expansion and 50% market share. Export volumes expected to rebound after Q4 slowdown; Latin American market inventory issues seem resolved. Fertilizer volumes normalized, with record production and expanded

Future growth expectations in earnings/operating earnings/profits/EPS?

Coromandel expects growth driven by increased manufacturing capacities, especially in active ingredients like Mancozeb (10,000 tons capacity expansion at Dahej and 20,000 tons at Sarigam). Crop protection business aims for aggressive 20%-25% revenue growth with new product launches and expanded import of active ingredients. Margin sustainability is expected, with crop protection EBITDA margins around 19%, aided by currency depreciation and export growth. Fertilizer margins face challenges due to raw material inflation, but potential government subsidy increases and price corrections may suppor

Current/ Expected Orderbook/ Pending Orders?

Dhaksha, Coromandel International's defense-related venture, is currently in a recovery mode with ongoing progress. The first order execution for Dhaksha is expected during the current year, which will boost confidence for repeat orders across various defense segments. The company is expanding Dhaksha’s facility to a larger location, expected to be ready by May. Strengthening R&D efforts to introduce new products in the next 6 to 9 months to realize the value of previous investments. The drone business has taken impairment due to long lead times in order execution, indicating some delays in or

IN US

Coromandel International LtdQ1 FY27Fertilizers & Agrochemicals

Coromandel International Ltd Q1 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹2,083P/E: 33.0Market Cap: ₹61.6K CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 2

→Crop Protection business expects 20%-25% revenue growth driven by new registrations, product launches (six new products), and increased active ingredient volumes, especially Mancozeb with new capacities at Dahej and Sarigam.
→Formulation business growth projected at 14%-20%, with niche and bio pesticide products gaining traction.
→Nano DAP segment shows strong growth, with 60% volume expansion and 50% market share.
→Export volumes expected to rebound after Q4 slowdown; Latin American market inventory issues seem resolved.
→Fertilizer volumes normalized, with record production and expanded unique grades at 35%.
→Retail business targets 30% growth by adding new stores and leveraging e-commerce and drone services.
→Drone business (Dhaksha) is in early growth phase, with planned new facility and product offerings within next 6-9 months.
→Overall, Coromandel aims to sustain healthy volume and revenue growth across segments with improved capacities and product portfolio.

Margin guidance

Category 3

→Coromandel expects growth driven by increased manufacturing capacities, especially in active ingredients like Mancozeb (10,000 tons capacity expansion at Dahej and 20,000 tons at Sarigam).
→Crop protection business aims for aggressive 20%-25% revenue growth with new product launches and expanded import of active ingredients.
→Margin sustainability is expected, with crop protection EBITDA margins around 19%, aided by currency depreciation and export growth.
→Fertilizer margins face challenges due to raw material inflation, but potential government subsidy increases and price corrections may support margin recovery.
→NACL acquisition is driving synergistic growth and profitability, with expected margin improvement to 9%-10% over time.
→The CDMO business is in early stages with multi-year gestation but has favorable prospects due to MNC interest.
→Overall, significant investments (INR 3,000+ crores) over the last two years are expected to generate target revenues and profits in coming periods.

3 more insights locked — sign up free to unlock

Fundraise plans

→There is no explicit mention of any current or future fundraising through debt or equity in the provided transcript.
→However, it is noted that the recently acquired NACL followed a rights issue of INR 250 crores to reduce high-cost debt.
→Coromandel International has made significant investments of over INR 3,000 crores in the last two years across business segments, indicating use of internal resources or financing, but no specific new fundraising is mentioned.
→The company is focusing on realizing value from current investments before making large new investments, particularly in the CDMO space.
→Overall, no new debt or equity fundraising plans are disclosed in the available content.

Order book

→Dhaksha, Coromandel International's defense-related venture, is currently in a recovery mode with ongoing progress.
→The first order execution for Dhaksha is expected during the current year, which will boost confidence for repeat orders across various defense segments.
→The company is expanding Dhaksha’s facility to a larger location, expected to be ready by May.
→Strengthening R&D efforts to introduce new products in the next 6 to 9 months to realize the value of previous investments.
→The drone business has taken impairment due to long lead times in order execution, indicating some delays in order book fulfillment.
→Overall, initial orders are being executed with expectations for repeat orders, but specific orderbook value or number details are not disclosed.

Capex plans

Yes

→Dhaksha facility expansion: Moving to a larger facility expected to be ready by May 2026, aiming to enhance drone production and execution of defense orders.
→Strengthening R&D: Plan to introduce new products in the next 6-9 months to capitalize on prior investments.
→Dahej plant: Expanded capacity by 10,000 tons of Mancozeb with payback less than one year; an additional 20,000-ton expansion underway at Sarigam expected by mid-2026.
→Technical MAP and seaweed granulation capacities are being set up in the specialty nutrient business to generate revenue in coming years.
→Fluorination chemistry investment: Planned in coming quarters to develop capabilities for CDMO space, aiming for significant contributions 2-3 years down the line without immediate large-scale investments.
→New Sulphuric acid plant at Kakinada commenced in Q4 2026, supporting internal requirements and cost management.

How does Coromandel International Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature

1Coromandel International Ltd

Rev 2Mar 3

See full Fertilizers & Agrochemicals sector rankings

Want more stocks like Coromandel International Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio